Success Item Removed From Cart

Basket Summary
Close

Your Cart is Empty

Subtotal
$0
Sales Tax
$0
Total
$0
Back to browsing

Artificial Pancreas Pipeline Market Report Overview

The artificial pancreas helps people with diabetes, primarily type 1, to automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

The artificial pancreas pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       South Korea

Key Regulatory Paths ·       PMA

·       CE

·       510(k)

·       NMPA

·       Shonin

Leading Companies ·       Admetsys Corp

·       Advanced Biosensors-Ohio LLC

·       AiTA Bio Inc

·       Beta-O2 Technologies Ltd

·       Bigfoot Biomedical Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Artificial Pancreas Pipeline Market Segmentation by Territories

A few of the key territories with the artificial pancreas pipeline market are the US, Europe, China, Japan, and South Korea. As of September 2024, the US accounted for the highest number of pipeline products.

Artificial Pancreas Pipeline Market Analysis by Territories, 2024 (%)

Artificial Pancreas Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Artificial Pancreas Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the artificial pancreas pipeline products market are PMA, CE, 510(k), NMPA, and Shonin. As of September 2024, PMA was the most followed pathway for pipeline products in the artificial pancreas market.

Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Artificial Pancreas Pipeline Market – Competitive Landscape

A few of the key companies associated with the artificial pancreas pipeline market are Admetsys Corp, Advanced Biosensors-Ohio LLC, AiTA Bio Inc, Beta-O2 Technologies Ltd, and Bigfoot Biomedical Inc., among others.

Beta-O2 Technologies Ltd: Headquartered in Rosh HaAyin, Israel, it is a biomedical company that develops proprietary implantable bio-artificial pancreas for the treatment of type 1 diabetes. The company’s bio-artificial pancreas is an implantable device that allows for immune isolation of the implanted cells, eliminating the need for frequent insulin injections, glucose measurements, and immunosuppressive therapy. Beta-O2 preclinically tests the bio-artificial adrenal as a treatment for stress disorders.

Bigfoot Biomedical Inc.: It is a medical device company that develops technologies to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. It leverages data, connectivity, automation, and machine learning to automatically and continuously optimize insulin delivery for people with insulin-requiring diabetes and maximize the leverage of healthcare providers. Bigfoot Biomedical provides automated infusion pumps and connected insulin pen options for consumers to meet the needs of a diverse population with insulin-requiring diabetes.

Artificial Pancreas Pipeline Market Analysis by Companies, 2024

Artificial Pancreas Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Artificial Pancreas Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • South Korea

Artificial Pancreas Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • 510(k)
  • NMPA
  • Shonin

Scope of Report

This report provides:

  • Extensive coverage of the artificial pancreas under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of artificial pancreas and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of artificial pancreas under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

FAQs

  • As of September 2024, the US accounted for the highest number of pipeline products in the artificial pancreas market.

  • As of September 2024, PMA was the most followed pathway for pipeline products in the artificial pancreas market.

  • A few of the key companies associated with the artificial pancreas pipeline market are Admetsys Corp, Advanced Biosensors-Ohio LLC, AiTA Bio Inc, Beta-O2 Technologies Ltd, and Bigfoot Biomedical Inc.

What our clients have to say

More Reports

View More Reports